• Accueil
  • Mediakit 🇫🇷 🇬🇧
    • Programme rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧
logo
  • Mediakit 🇫🇷 🇬🇧
    • Programme Rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
S'abonner / subscribe linkedin
  • Accueil
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧

Catalent Biologics extends its Bloomington facility

News 🇬🇧

publié le jeudi 30 avril 2020

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility.

The completed expansion adds 15,000 square feet of packaging infrastructure to the biologics and sterile manufacturing site, including five new packaging suites and a new quality control laboratory.
Catalent has developed strategic partnerships with industry leaders to bring new technologies and integrated capabilities to customers with three new state-of-the-art packaging lines, including an Optima combination syringe assembly machine, an automated Mikron auto-injector assembly machine, and a Dividella NeoTOP® x (NTX) top-load cartoner with both semi-automated and fully-automated configurations. All three high-speed lines are fully qualified and ready to provide customers faster and more flexible packaging solutions for vials, syringes, and devices with no glass-to-glass contact.
“The completion of this expansion marks a major milestone for our late-stage and commercial customers, allowing Catalent to focus on more complex device assembly and packaging needs for biologic products at higher volumes,” commented Mike Riley, Region President, Biologics North America. “This state-of-the-art equipment adds to our growing network of global packaging capabilities alongside our Brussels, Belgium, and Anagni, Italy drug product manufacturing sites”.
Catalent’s 875,000 square-feet facility in Bloomington has deep expertise in sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across liquid and lyophilized vials, prefilled syringes, and cartridges.

Part of 647 issue – April 20. All rights reserved except agreement written by Emballage Digest or mention of the magazine

Article Précédent
Anjac Health & Beauty annonce l’acquisition de Roval Cosmétiques
Article Suivant
New system for tailor-made Shaped Paper Pods

Industrie

Matériaux

News 🇬🇧

DIC India Inaugurates its new facility in Gujarat

publié le vendredi 24 mars 2023

Machines

News 🇬🇧

pharmacie

3D screen printing: new partnership between Hovione and Laxxon Medical

publié le jeudi 23 mars 2023

Matériel

News 🇬🇧

Termoplast relies on surface inspection systems from BST

publié le mercredi 22 mars 2023

Matériaux

News 🇬🇧

Securikett launches fully transparent security label with wow effect

publié le lundi 20 mars 2023

Abonnements

Trouvez l'abonnement qui vous convient

voir les offres
logo de Emballage Digest
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
  • News 🇬🇧
  • Derniers numéros
  • L’équipe
  • Mediakit 🇫🇷 🇬🇧
  • La Revue
  • Agenda
  • Podcasts & vidéos
Mentions légales | Site conçu et réalisé par DEV INFLUENCE

© EMBALLAGE DIGEST - Tous droits réservés